On May 6, the US Food and Drug Administration (FDA) announced plans to expand its use of unannounced inspections at foreign manufacturing ...

The FDA has said it plans to conduct more unannounced inspections at foreign facilities that produce food and medical products intended for Americans.

WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has announced its plan to increase the use of unannounced ...

The U.S. Food and Drug Administration said Tuesday it will expand its use of unannounced inspections at foreign manufacturing ...

The U.S. Food and Drug Administration (FDA) announced its intent to expand the use of unannounced inspections at foreign ...

The aim is to make sure that foreign companies "receive the same level of regulatory oversight and scrutiny as domestic ...

The FDA is ramping up oversight of foreign manufacturing sites by expanding its use of unannounced inspections, a move aimed at leveling the playing field between domestic and international drugmakers ...

On May 6, 2025, the U.S. Food and Drug Administration (FDA) announced that it intends to expand its use of unannounced inspections at ...

The U.S. Food and Drug Administration (FDA) announced Tuesday that it will increase unannounced inspections at foreign ...

The FDA says it conducts approximately 12,000 domestic inspections and 3,000 foreign inspections each year in more than 90 ...

For both foods and drugs, most foreign inspections were pre-announced; the agency also re-emphasized its ban on inspectors ...

The U.S. Food and Drug Administration (FDA) announced its intent to expand the use of unannounced inspections at foreign manufacturing facilities that produce foods, essential medicines ...